1.Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea
Jin Yong KIM ; Jae Hoon KO ; Yeonjae KIM ; Yae Jean KIM ; Jeong Min KIM ; Yoon Seok CHUNG ; Heui Man KIM ; Myung Guk HAN ; So Yeon KIM ; Bum Sik CHIN
Journal of Korean Medical Science 2020;35(7):86-
As of February 2020, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak started in China in December 2019 has been spreading in many countries in the world. With the numbers of confirmed cases are increasing, information on the epidemiologic investigation and clinical manifestation have been accumulated. However, data on viral load kinetics in confirmed cases are lacking. Here, we present the viral load kinetics of the first two confirmed patients with mild to moderate illnesses in Korea in whom distinct viral load kinetics are shown. This report suggests that viral load kinetics of SARS-CoV-2 may be different from that of previously reported other coronavirus infections such as SARS-CoV.
China
;
Coronavirus
;
Coronavirus Infections
;
Humans
;
Kinetics
;
Korea
;
SARS Virus
;
Severe Acute Respiratory Syndrome
;
Viral Load
3.Clinical features of coronavirus disease 2019 in children: a systemic review of severe acute respiratory syndrome, Middle East respiratory syndrome, and coronavirus disease 2019.
Yang HE ; Jun TANG ; Meng ZHANG ; Hao-Ran WANG ; Wen-Xing LI ; Tao XIONG ; You-Ping LI ; De-Zhi MU
Chinese Journal of Contemporary Pediatrics 2020;22(8):844-853
OBJECTIVE:
To systematically summarize the clinical features of coronavirus disease 2019 (COVID-19) in children.
METHODS:
PubMed, Embase, Web of Science, The Cochrane Library, CNKI, Weipu Database, and Wanfang Database were searched for clinical studies on COVID-19 in children published up to May 21, 2020. Two reviewers independently screened the articles, extracted data, and assessed the risk of bias of the studies included. A descriptive analysis was then performed for the studies. Related indices between children with COVID-19 and severe acute respiratory syndromes (SARS) or Middle East respiratory syndrome (MERS) were compared.
RESULTS:
A total of 75 studies were included, with a total of 806 children with COVID-19. The research results showed that the age of the children ranged from 36 hours after birth to 18 years, with a male-female ratio of 1.21 : 1. Similar to SARS and MERS, COVID-19 often occurred with familial aggregation, and such cases accounted for 74.6% (601/806). The children with COVID-19, SARS, and MERS had similar clinical symptoms, mainly fever and cough. Some children had gastrointestinal symptoms. The children with asymptomatic infection accounted for 17.9% (144/806) of COVID-19 cases, 2.5% (2/81) of SARS cases, and 57.1% (12/21) of MERS cases. The children with COVID-19 and MERS mainly had bilateral lesions on chest imaging examination, with a positive rate of lesions of 63.4% (421/664) and 26.3% (5/19) respectively, which were lower than the corresponding positive rates of viral nucleic acid detection, which were 99.8% and 100% respectively. The chest radiological examination of the children with SARS mainly showed unilateral lesion, with a positive rate of imaging of 88.9% (72/81), which was higher than the corresponding positive rate of viral nucleic acid detection (29.2%). Viral nucleic acid was detected in the feces of children with COVID-19 or SARS, with positive rates of 60.2% (56/93) and 71.4% (5/7) respectively. The children with COVID-19 had a rate of severe disease of 4.6% (31/686) and a mortality rate of 0.1% (1/806), the children with SARS had a rate of severe disease of 1.5% (1/68) and a mortality rate of 0%, and those with MERS had a rate of severe disease of 14.3% (3/21) and a mortality rate of 9.5% (2/21).
CONCLUSIONS
Children with COVID-19 have similar symptoms to those with SARS or MERS, mainly fever and cough. Asymptomatic infection is observed in all three diseases. Children with COVID-19 or SARS have milder disease conditions than those with MERS. COVID-19 in children often occurs with familial aggregation. Epidemiological contact history, imaging examination findings, and viral nucleic acid testing results are important bases for the diagnosis of COVID-19.
Betacoronavirus
;
Child
;
Coronavirus Infections
;
physiopathology
;
Cough
;
virology
;
Female
;
Fever
;
virology
;
Humans
;
Male
;
Middle East Respiratory Syndrome Coronavirus
;
Pandemics
;
Pneumonia, Viral
;
physiopathology
;
Severe Acute Respiratory Syndrome
;
physiopathology
;
virology
4.Emerging Infectious Diseases Require Biosafety Awareness and Procedures.
Kyung Min LEE ; Won Jong JANG ; Yeon Joo CHOI ; Kyung Hee PARK
Journal of Bacteriology and Virology 2016;46(2):104-107
In 2015, there was a Middle East respiratory syndrome (MERS) outbreak in Korea. Interestingly, most of the cases were nosocomial infection and significant numbers of healthcare workers (HCWs) were infected. There were various causes, but this study focused on HCWs and their ability to self-protect from infectious materials. HCWs did not receive sufficient instruction or training on biosafety, including how to use personal protection equipment and risk assessment at the beginning of the outbreak. Previous experience from an outbreak of severe acute respiratory syndrome or Ebola showed that HCWs must self-protect from infection sources, but HCW infection occurred again with this MERS outbreak. Therefore, the concept of biosafety self-protection must be emphasized so that HCWs can protect themselves from diseases and avoid spreading them.
Communicable Diseases, Emerging*
;
Coronavirus Infections
;
Cross Infection
;
Delivery of Health Care
;
Humans
;
Korea
;
Risk Assessment
;
Severe Acute Respiratory Syndrome
5.Verification with the utility of an established rapid assessment of brain safety for newly developed vaccines
Laboratory Animal Research 2019;35(4):180-186
In the twenty-first century, high contagious infectious diseases such as SARS (Severe Acute Respiratory Syndrome), MERS (Middle East Respiratory Syndrome), FMD (Foot-and-Mouth Disease) and AI (Avian Influenza) have become very prevalent, causing treat harm to humans and animals in aspect of public health, and economical issues. The critical problem is that newly-reported infectious diseases that humans firstly experience are expected to continue to emerge, and these diseases will be spreading out rapidly. Therefore, rapid and safe supplies of effective vaccines are most pivotal to prevent the rapid prevalent of new infection, but international standards or assessing protocol the safety of urgent vaccines are not established well. In our previous study, since we established a module to assess the brain safety of urgent vaccines, therefore, it is necessary to verify that this established module for assessing brain safety could work effectively in commercially available two vaccines (one killed- and on live-vaccines). We compared the results of Evans blue (EB) assay and qPCR analysis by injection of two kinds of vaccines, PBS and Lipopolysaccharide (LPS) under the condition of the module previously reported. We confirmed that the brain safety test module for urgent vaccine we established is very reproducible. Therefore, it is believed that this vaccine safety testing method can be used to validate brain safety when prompt supply of a newly developed vaccines is needed.
Animals
;
Brain
;
Communicable Diseases
;
Coronavirus Infections
;
Equipment and Supplies
;
Evans Blue
;
Humans
;
Methods
;
Public Health
;
Severe Acute Respiratory Syndrome
;
Vaccines
6.From severe acute respiratory syndrome-associated coronavirus to 2019 novel coronavirus outbreak: similarities in the early epidemics and prediction of future trends.
Ze-Liang CHEN ; Wen-Jun ZHANG ; Yi LU ; Cheng GUO ; Zhong-Min GUO ; Cong-Hui LIAO ; Xi ZHANG ; Yi ZHANG ; Xiao-Hu HAN ; Qian-Lin LI ; Jia-Hai LU
Chinese Medical Journal 2020;133(9):1112-1114
8.The interdependent complexity of disaster and Middle East Respiratory Syndrome.
Epidemiology and Health 2016;38(1):e2016053-
No abstract available.
Coronavirus Infections*
;
Disasters*
;
Middle East*
9.Understanding and Modeling the Super-spreading Events of the Middle East Respiratory Syndrome Outbreak in Korea.
Infection and Chemotherapy 2016;48(2):147-149
No abstract available.
Coronavirus Infections*
;
Korea*
;
Middle East*
10.Strategies for vaccine development of COVID-19.
Limin YANG ; Deyu TIAN ; Wenjun LIU
Chinese Journal of Biotechnology 2020;36(4):593-604
An epidemic of acute respiratory syndrome in humans, which appeared in Wuhan, China in December 2019, was caused by a novel coronavirus (SARS-CoV-2). This disease was named as "Coronavirus Disease 2019" (COVID-19). SARS-CoV-2 was first identified as an etiological pathogen of COVID-19, belonging to the species of severe acute respiratory syndrome-related coronaviruses (SARSr-CoV). The speed of both the geographical transmission and the sudden increase in numbers of cases is much faster than SARS and Middle East respiratory syndrome (MERS). COVID-19 is the first global pandemic caused by a coronavirus, which outbreaks in 211 countries/territories/areas. The vaccine against COVID-19, regarded as an effective prophylactic strategy for control and prevention, is being developed in about 90 institutions worldwide. The experiences and lessons encountered in the previous SARS and MERS vaccine research can be used for reference in the development of COVID-19 vaccine. The present paper hopes to provide some insights for COVID-19 vaccines researchers.
Betacoronavirus
;
immunology
;
Biomedical Research
;
Coronavirus Infections
;
epidemiology
;
immunology
;
prevention & control
;
virology
;
Humans
;
Internationality
;
Middle East Respiratory Syndrome Coronavirus
;
immunology
;
Pandemics
;
prevention & control
;
Pneumonia, Viral
;
epidemiology
;
immunology
;
prevention & control
;
virology
;
SARS Virus
;
immunology
;
Severe Acute Respiratory Syndrome
;
immunology
;
Viral Vaccines
;
immunology